WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors.

Authors

Pierre Gaudreau, University of Texas MD Anderson Cancer Center
Sylvie Clairefond, Université de Montréal
Caleb Class, University of Texas MD Anderson Cancer Center
Pierre Boulay, Université de Montréal
Pavel Chrobak, Université de Montréal
Bertrand Allard, Université de Montréal
Feryel Azzi, Centre de Recherche du Centre Hospitalier Universitaire de Montréal (CRCHUM)/Institut du Cancer de Montréal, Montreal, QC, Canada.
Sandra Pommey, Université de Montréal
Kim Anh, University of Texas MD Anderson Cancer Center
Fred Saad, Département d'Urologie du Centre Hospitalier Universitaire de Montréal (CHUM) et Institut du Cancer de Montréal / CRCHUM, Montreal, QC, Canada.
Dominique Trudel, Université de Montréal
Marian Young, National Institutes of Health
John Stagg, Université de Montréal

Document Type

Article

Publication Date

March 2019

Publication Title

OncoImmunology

DOI

10.1080/2162402X.2019.1581545

Recommended Citation

Gaudreau, Pierre; Clairefond, Sylvie; Class, Caleb; Boulay, Pierre; Chrobak, Pavel; Allard, Bertrand; Azzi, Feryel; Pommey, Sandra; Anh, Kim; Saad, Fred; Trudel, Dominique; Young, Marian; and Stagg, John, "WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors." (2019). Scholarship and Professional Work – COPHS. 265.
https://digitalcommons.butler.edu/cophs_papers/265